Concepedia

Kay Noel

KN

3

Publications

244

Citations

3

H-Index

2013

Active since

Affiliations

MSD (Switzerland)(Current)

Hôpital René Huguenin

Mario Negri Institute for Pharmacological Research

Kay Noel is an author at MSD (Switzerland) specializing in drug discovery, medicinal chemistry, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2013–2016

3

Publications

3

OTX015 (MK‐8628), a novel BET inhibitor, displays <i>in vitro</i> and <i>in vivo</i> antitumor effects alone and in combination with conventional therapies in glioblastoma models

Caroline Berenguer‐Daizé, Lucile Astorgues‐Xerri, Elodie Odore et al. · International Journal of Cancer · 2016 · 147 citations · Full text

OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations

María E. Riveiro, Lucile Astorgues‐Xerri, Ramiro Vázquez et al. · Oncotarget · 2016 · 58 citations · Full text

Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib

Massimo Zucchetti, Katiuscia Bonezzi, Roberta Frapolli et al. · Cancer Chemotherapy and Pharmacology · 2013 · 39 citations

, , +7

Rows per page

1–3 of 3